Ignite Creation Date:
2024-05-06 @ 9:45 AM
Last Modification Date:
2024-10-26 @ 12:19 PM
Study NCT ID:
NCT03068715
Status:
COMPLETED
Last Update Posted:
2022-05-18
First Post:
2017-02-20
Brief Title:
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression SAINT-TRD
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression SAINT-TRD
Status:
COMPLETED
Status Verified Date:
2022-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
aTBS
Brief Summary:
This study evaluates an accelerated schedule of theta-burst stimulation using a transcranial magnetic stimulation device for treatment-resistant depression In a double-blind fashion half the participants will receive accelerated theta-burst stimulation while half will receive sham treatment
Detailed Description:
Repetitive transcranial magnetic stimulation rTMS is an established therapy for treatment-resistant depression The approved method for treatment is 10Hz stimulation for 40 min over the left dorsolateral prefrontal cortex L-DLPFC This methodology has been effective in real world situations The limitations of this approach include the duration of the treatment approximately 40 minutes per treatment session 5 days per week for 4-8 weeks Recently researchers have pursued modifying the treatment parameters to reduce treatment times with some preliminary successes This study aims to further modify the parameters to create a more rapid form of the treatment and look at the change in neuroimaging biomarkers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None